Despite increases in earnings and net income, Walgreens shares dropped this week after the company’s third-quarter earnings fell short of Wall Street expectations.
Despite increases in earnings and net income, Walgreens shares dropped this week after the company’s third-quarter earnings fell short of Wall Street expectations.
The company’s adjusted earnings for the quarter increased 29.3% to $812 million, or 85 cents a share. That was 6 cents less than what analysts forecast.
Meanwhile, net income for the quarter jumped 16.2% to $624 million, or 65 cents a share. Walgreens net income for the same period last year was $537 million, or 62 cents a share. On Tuesday, Walgreens stock dropped nearly 6% and closed at $45.22.
“Our front-end sales are still not up to our expectations, and while the economy remains challenging, increasing customer traffic and front-end sales are our near-term priorities with a focus on pricing and promotion and the leveraging of our Balance Rewards program, which now has 75 million members,” said Greg Wasson, Walgreen’s CEO.
Walgreens’ third quarter sales rose 3.2% to $18.3 billion, which included an 8.7% increase in prescription volume. However, the company reported that customer traffic in stores decreased by 3.9%.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831